{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:46:59Z","timestamp":1771062419025,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jbspin.2018.01.014","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T17:50:34Z","timestamp":1518544234000},"page":"721-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index"],"prefix":"10.1016","volume":"85","author":[{"given":"Andreu","family":"Fern\u00e1ndez-Codina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Pinilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iago","family":"Pinal-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Fraile-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Fonseca-Aizpuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iago","family":"Carballo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Brito-Zer\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Feij\u00f3o-Mass\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"L\u00f3pez-Dupla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cinta","family":"Cid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Mart\u00ednez-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2018.01.014_bib0140","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08916934.2017.1280029","article-title":"Clonally expanded cytotoxic CD4(+) T cells and the pathogenesis of IgG4-related disease","volume":"50","author":"Mattoo","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD)","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0155","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Pleande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.autrev.2016.12.008","article-title":"IgG4-related disease: evidence from six recent cohorts","volume":"16","author":"Mart\u00ednez-Valle","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0165","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00535-014-0945-z","article-title":"Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis","volume":"49","author":"Kamisawa","year":"2014","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0170","first-page":"1","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0175","doi-asserted-by":"crossref","first-page":"e4002","DOI":"10.1097\/MD.0000000000004002","article-title":"Therapeutic approach to IgG4-related disease","volume":"95","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0180","first-page":"168","article-title":"PlasmabIgG4-related disease: pathophysiologic insights drive emerging treatment approaches","volume":"34","author":"Stone","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0185","doi-asserted-by":"crossref","first-page":"259408","DOI":"10.1155\/2012\/259408","article-title":"Development of an IgG4-RD responder index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0190","doi-asserted-by":"crossref","first-page":"e1275","DOI":"10.1097\/MD.0000000000001275","article-title":"IgG4-Related disease: results from a multicenter Spanish registry","volume":"94","author":"Fern\u00e1ndez-Codina","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0195","first-page":"1","article-title":"IgG4-related disease: clinical and laboratory features in 125 patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheum (Hoboken, NJ)"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0200","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0205","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0210","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","article-title":"Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients","volume":"54","author":"Lin","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","article-title":"IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry","volume":"91","author":"Ebbo","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0220","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","article-title":"A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham vasculitis activity score","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","article-title":"IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients","volume":"45","author":"Campochiaro","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0230","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0235","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0240","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14397595.2016.1259602","article-title":"A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease","volume":"27","author":"Masaki","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0245","doi-asserted-by":"crossref","first-page":"e6400","DOI":"10.1097\/MD.0000000000006400","article-title":"Poor response of initial steroid therapy for IgG4-related sclerosing cholangitis with multiple organs affected","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0250","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","article-title":"Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids","volume":"7","author":"Yunyun","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0255","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/rheumatology\/kev244","article-title":"Methotrexate for maintenance of remission in igg4-related disease","volume":"54","author":"Della-torre","year":"2015","journal-title":"Rheumatology (United Kingdom)"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0260","doi-asserted-by":"crossref","first-page":"kev438","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2018.01.014_bib0265","doi-asserted-by":"crossref","first-page":"e0183844","DOI":"10.1371\/journal.pone.0183844","article-title":"Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients","volume":"12","author":"Ebbo","year":"2017","journal-title":"PLoS One"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18300174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18300174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:23:47Z","timestamp":1761150227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X18300174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1297319X18300174"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.01.014","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}